Analysis of the vectorial transport of amino acid and drugs in epithelial cells.

上皮细胞中氨基酸和药物的载体运输分析。

基本信息

  • 批准号:
    12144201
  • 负责人:
  • 金额:
    $ 32.77万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2004
  • 项目状态:
    已结题

项目摘要

We investigated multiplicity of the transporters involved in vectorial transport of amino acids and drugs in epithelial cells as well as the regulatory mechanism of their membrane trafficking. The region of BCRP necessary for its apical sorting was identified. Contribution of transporters to the drug-transport was investigated in kidney and choroid plexus (OAT1 and OAT3, and PEPT2 andOAT3, respectively). Functional characterization of MRP3 and BCRP was performed, and their involvement in drug-transport in the small intestine has been suggested. Uptake (OATP2) and efflux (MRP2) transporters were co-expressed in a polarized cell line (MDCK II) as an in vitro model of hepatobiliary transport of organic anions. In vitro. transcellular transport across P-gp-expressing monolayers can be used to predict the extent to which intestinal absorption and brain uptake is affected by Pigp. Furthermore, using a double transfectant (Oatp4/Mrp2), in vitro transcellular transport can be used to predict h … More epatobiliary clearance of organic anions. Double-transfectants expressing Ntcp and Bsep was established as model of hepatobiliary transport of bile acids.Seven amino acid transporters (Asc-2, AGT1, TAT1, LAT3, LAT4, CAT5 and B^0AT1) were newly cloned, and their functional characterization was performed. As luminal transporter for organic anions in the kidney, OATv1, URAT1 and OAT7 were cloned, and their functional characterization was performed. Mutations in B0AT1 and URAT1 cause Hartnup disorder and renal hypouricemia, respectively. Transmembrane domain of rBAT and 4F2hc is necessary for its interaction with their partner molecules. The "VVPP" sequence at C-terminus of BAT1 is essential for its membrane sorting. RACK1 was isolated by yeast-two-hybrid using the sequence as bait. RACK1 is a scaffold-protein contains multiple PDZ motifs, and we confirmed that it interacts with "VVPP" sequence of BAT1. The PDZ interacting motif at the C-terminus of URAT1 interacts with PDZK1. PDZ interactions may play an important role in clustering transporters. Less
我们研究了上皮细胞中参与氨基酸和药物载体转运的转运蛋白的多样性及其膜转运的调控机制。确定了其顶端分选所需的BCRP区域。在肾脏和脉络丛中研究转运蛋白对药物转运的贡献(分别为OAT 1和OAT 3,以及PEPT 2和OAT 3)。对MRP 3和BCRP进行了功能表征,并表明它们参与了小肠中的药物转运。在极化细胞系(MDCK II)中共表达摄取(OATP 2)和外排(MRP 2)转运蛋白,作为有机阴离子肝胆转运的体外模型。体外跨P-gp表达单层的跨细胞转运可用于预测肠吸收和脑摄取受Pigp影响的程度。此外,使用双转染子(Oatp 4/Mrp 2),体外跨细胞转运可用于预测细胞凋亡。 ...更多信息 有机阴离子的上胆汁清除。建立了表达Ntcp和Bsep的双转染细胞作为胆汁酸肝胆转运的模型,并克隆了7个新的氨基酸转运蛋白(Asc-2,AGT 1,TAT 1,LAT 3,LAT 4,CAT 5和B^0AT1),并对其功能进行了研究。作为肾脏中有机阴离子的腔转运蛋白,OATv 1、URAT 1和OAT 7被克隆,并进行了功能表征。B 0AT 1和URAT 1的突变分别引起Hartnup病和肾性低尿酸血症。rBAT和4F 2 hc的跨膜结构域是rBAT和4F 2 hc与它们的伴侣分子相互作用所必需的。BAT 1的C端的“VVPP”序列是其膜分选所必需的。以该序列为诱饵,利用酵母双杂交技术分离RACK 1。RACK 1是一个含有多个PDZ基序的支架蛋白,我们证实它与BAT 1的“VVPP”序列相互作用。URAT 1 C末端的PDZ相互作用基序与PDZK 1相互作用。PDZ相互作用可能在聚集转运蛋白中起重要作用。少

项目成果

期刊论文数量(602)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
金井好克: "アミノ酸トランスポーター"Annual Review 腎臓 2001、伊藤克己, 浅野泰, 遠藤仁, 御手洗哲也, 東原英二編(中外医学社). 8 (2001)
Yoshikatsu Kanai:《氨基酸转运蛋白》肾脏年度评论 2001,由 Katsumi Ito、Yasushi Asano、Hitoshi Endo、Tetsuya Mitarai 和 Eiji Higashihara 编辑(Chugai Igakusha)8 (2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Identification of a novel voltage-driven organic anion transporter present at apical membrane of renal proximal tubule
  • DOI:
    10.1074/jbc.m303210200
  • 发表时间:
    2003-07-25
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Jutabha, P;Kanai, Y;Endou, H
  • 通讯作者:
    Endou, H
Enomoto A et al.: "Molecular identification of a renal urate/anion exchanger that regulates blood urate levels"Nature. 417. 447-452 (2002)
Enomoto A 等人:“调节血尿酸盐水平的肾尿酸盐/阴离子交换剂的分子鉴定”自然。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters
  • DOI:
    10.1074/jbc.m305221200
  • 发表时间:
    2003-10-31
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Babu, E;Kanai, Y;Endou, H
  • 通讯作者:
    Endou, H
尿素トランスポーターの分子実体と尿濃縮における役割
尿素转运蛋白的分子实体及其在尿液浓度中的作用
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sugimoto K;et al.;金井 好克
  • 通讯作者:
    金井 好克
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUGIYAMA Yuichi其他文献

SUGIYAMA Yuichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUGIYAMA Yuichi', 18)}}的其他基金

Development of probe drugs for the evaluation of the functions of drug transporters in vivo in humans
开发用于评估人体内药物转运蛋白功能的探针药物
  • 批准号:
    20249008
  • 财政年份:
    2008
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of the quantitative prediction method of pharmacokinetics with considering the function of metabolic enzymes and transporters
考虑代谢酶和转运蛋白功能的药代动力学定量预测方法的开发
  • 批准号:
    17209005
  • 财政年份:
    2005
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
New strategy for the drug development of CNS acting drugs by regulating drug transport across the blood-brain barrier
通过调节药物跨血脑屏障转运开发中枢神经系统药物的新策略
  • 批准号:
    15390035
  • 财政年份:
    2003
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of the system for prediction of drug-drug interactions in hepatobiliary transport process
肝胆转运过程中药物相互作用预测系统的开发
  • 批准号:
    13557219
  • 财政年份:
    2001
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Drug design based on the substrate specificity of the efflux transporters expressed in the blood-brain barrier
基于血脑屏障中表达的外排转运蛋白的底物特异性的药物设计
  • 批准号:
    13470495
  • 财政年份:
    2001
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of the factors governing the elimination route of therapeutic agents
控制治疗药物消除途径的因素分析
  • 批准号:
    11470509
  • 财政年份:
    1999
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Role of hepatic transporters in the detoxification
肝脏转运蛋白在解毒中的作用
  • 批准号:
    10044243
  • 财政年份:
    1998
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Development of recombinant proteins with an aim to increase their therapeutic activity by the regulation of intracellular sorting
开发重组蛋白,旨在通过调节细胞内分选来提高其治疗活性
  • 批准号:
    10557230
  • 财政年份:
    1998
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of hepatic transporters in the detoxification
肝脏转运蛋白在解毒中的作用
  • 批准号:
    09044267
  • 财政年份:
    1997
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Analysis of multiplicity and polymorphism of drug transporters expressed in the liver.
肝脏中表达的药物转运蛋白的多样性和多态性分析。
  • 批准号:
    09470501
  • 财政年份:
    1997
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
  • 批准号:
    10751760
  • 财政年份:
    2024
  • 资助金额:
    $ 32.77万
  • 项目类别:
SBIR Phase I: Engineered Induced Thymic Epithelial Cells for Novel T Cell Immunotherapies
SBIR 第一期:用于新型 T 细胞免疫疗法的工程诱导胸腺上皮细胞
  • 批准号:
    2234041
  • 财政年份:
    2023
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Standard Grant
Elucidation of switching mechanism in the Wnt pathway of human amniotic epithelial cells
阐明人羊膜上皮细胞Wnt通路的转换机制
  • 批准号:
    23K15421
  • 财政年份:
    2023
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 32.77万
  • 项目类别:
Structural diversity of ceramide moiety responsible for apical membrane function of bladder transitional epithelial cells
负责膀胱移行上皮细胞顶膜功能的神经酰胺部分的结构多样性
  • 批准号:
    23K08792
  • 财政年份:
    2023
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of fasting-induced radioprotection of small intestinal epithelial cells
禁食诱导的小肠上皮细胞辐射防护机制
  • 批准号:
    10645872
  • 财政年份:
    2023
  • 资助金额:
    $ 32.77万
  • 项目类别:
Epigenetic regulation of lineage specification in colon epithelial cells
结肠上皮细胞谱系规范的表观遗传调控
  • 批准号:
    10676682
  • 财政年份:
    2023
  • 资助金额:
    $ 32.77万
  • 项目类别:
Study of the instability among mutant epithelial cells, adjacent normal epithelial cells and stromal cells to develop strategies for screening and very early detection of cancer.
研究突变上皮细胞、邻近正常上皮细胞和基质细胞之间的不稳定性,以制定癌症筛查和极早期检测策略。
  • 批准号:
    23H03102
  • 财政年份:
    2023
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
MICA: Interrogating the functional impact of novel asthma genetic variants using genomics and inducible pluripotent stem cell-derived epithelial cells
MICA:利用基因组学和诱导多能干细胞衍生的上皮细胞探讨新型哮喘遗传变异的功能影响
  • 批准号:
    MR/X000974/1
  • 财政年份:
    2023
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Fellowship
Efficient, controlled delivery of synthetic anion carriers to epithelial cells for CFTR replacement therapy
高效、受控地将合成阴离子载体递送至上皮细胞,用于 CFTR 替代疗法
  • 批准号:
    2904232
  • 财政年份:
    2023
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了